| |
| |
|
| Insider
Information: |
Gowen Maxine |
| Relationship: |
Director |
| City: |
W. Conshohocken |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
127,977 |
|
|
Indirect Shares
|
1,581,525 |
|
|
| Direct
Value |
$74,880 |
|
|
|
Indirect Value
|
$162,661 |
|
|
| Total
Shares |
1,709,502 |
|
|
| Total
Value |
$237,540 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -15.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Santarus Inc |
SNTS |
former Director |
2004-04-06 |
20,000 |
2004-10-25 |
1,165,513 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2008-04-11 |
0 |
Premium* |
|
|
Trevena Inc |
TRVN |
President & CEO, Direc... |
2019-02-01 |
54,000 |
2019-02-01 |
416,012 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2020-06-08 |
24,133 |
2014-11-13 |
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
|
2017-01-04 |
17,543 |
2023-08-10 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2023-06-02 |
12,301 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACGN |
Aceragen, Inc |
|
– • – |
2023-08-10 |
4 |
S |
$0.51 |
$26 |
I/I |
(51) |
0 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,507 |
12,301 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2022-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,356 |
7,794 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-08 |
4 |
AS |
$12.05 |
$55,032 |
D/D |
(4,567) |
24,133 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
28,700 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2020-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,438 |
4,438 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
15,000 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2019-02-01 |
4 |
B |
$1.02 |
$51,000 |
D/D |
50,000 |
54,000 |
2.81 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-05-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
403 |
195,512 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
403 |
4,000 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-03-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
60,000 |
216,500 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-03-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
4,403 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-03-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
64,403 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-03-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
50,000 |
195,109 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-02-23 |
4 |
OE |
$0.68 |
$75,295 |
D/D |
110,403 |
126,903 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-01-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,500 |
145,109 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-01-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
114,403 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-01-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
150,000 |
150,000 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2017-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
150,000 |
4,000 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2017-01-04 |
4 |
A |
$1.50 |
$10,500 |
D/D |
7,000 |
17,543 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2016-11-07 |
4 |
B |
$4.10 |
$51,250 |
D/D |
12,500 |
16,500 |
2.81 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2016-10-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
14,084 |
139,109 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2016-10-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
14,084 |
4,000 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2016-10-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
145,025 |
18,084 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2016-10-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
145,025 |
144,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
